Cellebrite DI (NASDAQ:CLBT) Shares Up 1.2%

Cellebrite DI Ltd. (NASDAQ:CLBTGet Rating) shares traded up 1.2% during trading on Friday . The company traded as high as $4.18 and last traded at $4.18. 9,282 shares were traded during mid-day trading, a decline of 94% from the average session volume of 152,588 shares. The stock had previously closed at $4.13.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CLBT shares. Bank of America cut Cellebrite DI from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $6.50 to $6.00 in a research report on Friday, August 12th. William Blair lowered shares of Cellebrite DI from an “outperform” rating to a “market perform” rating in a report on Friday, August 12th. Cowen reduced their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, August 12th. Cowen reduced their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, August 12th. Finally, Needham & Company LLC increased their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the stock a “buy” rating in a report on Thursday, August 11th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $9.71.

Cellebrite DI Stock Performance

The business’s fifty day simple moving average is $5.02 and its 200-day simple moving average is $5.35. The firm has a market capitalization of $797.52 million, a PE ratio of 5.58, a price-to-earnings-growth ratio of 10.13 and a beta of 0.87.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Blair William & Co. IL bought a new stake in Cellebrite DI in the fourth quarter worth $135,000. Diametric Capital LP bought a new stake in Cellebrite DI in the fourth quarter worth $209,000. ETF Managers Group LLC bought a new stake in Cellebrite DI in the fourth quarter worth $462,000. Greenhaven Road Investment Management L.P. bought a new stake in Cellebrite DI in the fourth quarter worth $9,453,000. Finally, Yarbrough Capital LLC bought a new stake in Cellebrite DI in the first quarter worth $414,000. 20.41% of the stock is currently owned by institutional investors.

About Cellebrite DI

(Get Rating)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.

Further Reading

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.